Back
Abbott Laboratories Quote, Financials, Valuation and Earnings
Sponsored
ABT
Sponsored
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
50
ABT
Abbott Laboratories
Last Price:
105.93
Seasonality Move:
3.4%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to SeeAbbott Laboratories Price Quote
$105.93
-1.66 (-1.54%)
(Updated: April 24, 2024 at 10:25 AM ET)
Abbott Laboratories Key Stats
Sell
50
Abbott Laboratories (ABT)
is a Sell
Day range:
$107.31 - $108.11
52-week range:
$89.67 - $121.64
Dividend yield:
1.97%
P/E ratio:
33.00
P/S ratio:
4.67
P/B ratio:
4.84%
Volume:
3.8M
Avg. volume:
6.7M
1-year change:
-3.65%
Market cap:
$186.7B
Revenue:
$40.1B
EPS:
$3.21
How Much Does Abbott Laboratories Make?
-
How Much Are Abbott Laboratories's Sales Annually?
ABT Revenues are $40.1B -
How Much Profit Does Abbott Laboratories's Make A Year?
ABT net income is $5.7B
Is Abbott Laboratories Growing As A Company?
-
What Is Abbott Laboratories's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.02% -
What Is Abbott Laboratories's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.07%
Abbott Laboratories Stock Price Performance
-
Did Abbott Laboratories Stock Go Up Last Month?
Abbott Laboratories share price went down by -2.7% last month -
Did ABT's Share Price Rise Over The Last Year?
ABT share price fell by -3.65% over the past 1 year
What Is Abbott Laboratories 52-Week High & Low?
-
What Is Abbott Laboratories’s 52-Week High Share Price?
Abbott Laboratories has traded as high as $121.64 over the past 52 weeks -
What Is Abbott Laboratories’s 52-Week Low Share Price?
Abbott Laboratories has traded as low as $89.67 over the past 52 weeks
Abbott Laboratories Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Abbott Laboratories?
-
How Much Debt Does Abbott Laboratories Have?
Total long term debt quarterly is $0 -
How Much Cash Does Abbott Laboratories Have?
Cash and short term investments quarterly total is $7.3B -
What Is Abbott Laboratories’s Book Value Per Share?
Book value per share is 22.26
Is Abbott Laboratories Cash Flow Positive?
-
What Is ABT Cash Flow From Operations?
Cash flow from operations (TTM) is $7.3B -
What Is Abbott Laboratories’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$7.1B -
What Is Abbott Laboratories’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$3.1B
Abbott Laboratories Return On Invested Capital
-
Is Management Doing A Good Job?
ABT return on invested capital is 10.47% -
What Is Abbott Laboratories Return On Assets?
ROA measures how assets are converting to revenues and is 7.7% -
What Is ABT Return On Equity?
ROE is a measure of profitability and is 15.22%
Abbott Laboratories Earnings Date & Stock Price
-
What Is Abbott Laboratories's Stock Price Today?
A single share of ABT can be purchased today for 107.59 -
What Is Abbott Laboratories’s Stock Symbol?
Abbott Laboratories trades on the S&P500 under the ticker symbol: ABT -
When Is Abbott Laboratories’s Next Earnings Date?
The next quarterly earnings date for Abbott Laboratories is scheduled on July 19, 2024 -
When Is ABT's next ex-dividend date?
Abbott Laboratories's next ex-dividend date is April 12, 2024 -
How To Buy Abbott Laboratories Stock?
You can buy Abbott Laboratories shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Abbott Laboratories Competitors
-
Who Are Abbott Laboratories's Competitors?
Below is a list of companies who compete with Abbott Laboratories or are related in some way:
Abbott Laboratories Dividend Yield
-
What Is ABT Dividend Yield?
Abbott Laboratories’s dividend yield currently is 1.97% -
What Is Abbott Laboratories’s Payout Ratio?
Abbott Laboratories’s payout ratio is 47.35% -
When Did Abbott Laboratories Last Pay A Dividend?
The latest dividend pay date is April 24, 2024 -
What Is Abbott Laboratories’s Dividend Per Share?
Abbott Laboratories pays a dividend of $0.55 per share
Abbott Laboratories Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -6.67% | 0.04% |
Revenue: | 2.23% | 0.55% |
Analyst Recommendations
Buy Recommendations: | 12 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 126.33 |
Upside from Last Price: | 17.42% |